Manager, Immunology MSL at Bristol-Myers Squibb

Kariya-shi, Aichi, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Advanced scientific degree (e.g., PharmD, MD, PhD) in a relevant field (implied for MSL role)
Expertise in Immunology therapeutic area
Ability to engage in peer-to-peer scientific dialogue with Thought Leaders (RTLs, NTLs, academic and community TLs)
Field-based role requiring >90% time interacting with external stakeholders (investigators, clinical thought leaders)
Capability to capture medical insights and act as clinical & scientific advisor to internal cross-functional partners
Alignment of interactions with enterprise and medical strategies
Focus on peri-launch activities and lifecycle needs of the brand
Availability for scheduled "Medical on Call" to answer unsolicited off-label and complex questions virtually in real-time
High level of therapeutic expertise

Responsibilities

Develop trusted relationships with appropriate academic and community Thought Leaders (TLs) in Immunology through high-quality peer-to-peer scientific dialogue (proactive and reactive, via 1:1, group presentations, virtual channels)
Collaborate and engage in scientific dialogue with TLs to gain insights on clinical landscape and develop product/disease area-focused medical plans for effective launch and Lifecycle Management (LCM) activities
Proactively engage in scientific and clinical conversations to support medical plans, launch, and LCM
Engage with medical societies and Patient Advocacy Groups (PAGs) as appropriate (with Corporate Affairs)
Provide training for external speakers as needed
Provide medical support to address unsolicited HCP questions in real-time (face-to-face and via Medical on Call virtual capability)
Engage in educational dialogue with relevant HCPs, sharing clinical evidence and information based on physicians’ needs and field medical plan
Ensure medical community is fully apprised of safe and effective use of BMS medicines to support patient access
Appropriately document and achieve annual objectives (implied)

Skills

Immunology

Medical Science Liaison

Thought Leader Engagement

Scientific Dialogue

Clinical Evidence

Medical Affairs

Healthcare Professionals

KOL Management

Patient Access Strategies

Medical Insights

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free